Patient safety,pharmacovigilance and liability through the current vaccine crisis,disaster in pharmaceutical promotion and various global patient safety concerns
Restricted accessEditorialFirst published online November, 2024
Patient safety,pharmacovigilance and liability through the current vaccine crisis,disaster in pharmaceutical promotion and various global patient safety concerns
TayarJHLopez‐OlivoMASuarez‐AlmazorME. Febuxostat for treating chronic gout. Cochrane Database Syst Rev2012; 11(11): CD008653. DOI: 10.1002/14651858.CD008653.pub2 (accessed 18 October 2024).
3.
Jaspreet Kaur Sidhu and Deepti Chopra. Febuxostat induced Stevens Johnson syndrome: A case report. Int J Risk Saf Med2024, Inpress.
4.
BolcatoVBasileGTronconiLP, et al.Telemedicine in Italy: Healthcare authorization profiles in the modern medico-legal reading. Int J Risk Saf Med. 2024. DOI: 10.3233/JRS-240004.
5.
JablonowskiKHookerB. Adverse outcome detection of childhood administered thimerosal-free HibTITER®. Int J Risk Saf Med2024, Inpress.
6.
KiddeerMBasitAAhmadT, et al.Needle stick injuries and post-exposure prophylaxis practices among healthcare personnel working at tertiary care hospitals in Punjab, Pakistan. Int J Risk Saf Med2024; vol. Pre-press, no. Pre-press: 1–12.
7.
RhodesPIgnatius ParryP. Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines. Int J Risk Saf Med2024, Inpress.
